Skip to main content Skip to navigation
Anti-Human CD63 FITC/CD123 PE/HLA-DR PerCP

Anti-Human CD63 FITC/CD123 PE/HLA-DR PerCP

(RUO (GMP))
Product Details
Down Arrow Up Arrow


BD FastImmune™
Human
Flow cytometry
RUO (GMP)
Phosphate buffered saline with BSA and 0.1% sodium azide.


Description

The CD63 antibody, clone H5C6, is derived from the fusion of P3x653 Ag8 myeloma cells with splenocytes from BALB/c mice immunized with human splenic adherent cells.

The CD123 antibody, clone 9F5, is derived from fusion of NS-1 cells with splenocytes from BALB/c mice immunized with IL-3Rα transfected COS cells.

Anti–HLA-DR, clone L243, is derived from the hybridization of NS-1/1-Ag4 mouse myeloma cells with spleen cells from BALB/c mice immunized with the human lymphoblastic B-cell line RPMI 8866.

The CD63 antibody reacts with a 53-kilodalton (kDa), type III lysosomal glycoprotein found in many cell types, including monocytes, platelets, and basophils. This molecule is also referred to as LIMP, gp55, melanoma-associated antigen ME491, Pltgp40, LAMP- 3, and is a member of the tetraspannin transmembrane 4 superfamily (TM4SF).

he CD123 antibody (Anti–IL-3Rα) binds to the α-chain of the interleukin-3 receptor (IL-3Rα). It selectively recognizes COS cells that have been transfected with IL-3Rα. Clone 9F5 does not block IL-3 binding to the receptor.

Anti–HLA-DR recognizes a human class II major histocompatibility complex (MHC) antigen. The antigen is a transmembrane glycoprotein composed of α and β subunits that have molecular weights of 36 and 27 kilodaltons (kDa), respectively.

Preparation And Storage

Store vials at 2°C–8°C. Conjugated forms should not be frozen. Protect from exposure to light. Each reagent is stable until the expiration date shown on the bottle label when stored as directed.

341068 Rev. 1
Components
Down Arrow Up Arrow
Description Clone Isotype EntrezGene ID
Anti-HLA-DR PerCP L243 IgG2a, κ N/A
CD123 PE 9F5 IgG1, κ 3563
CD63 FITC N/A N/A N/A
341068 Rev. 1
Citations & References
Down Arrow Up Arrow

Development References (31)

  1. Agis H, Beil WJ, Bankl HC, et al. Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping. Leuk Lymphoma. 1996; 22:187-204. (Biology).
  2. Agis H, Füreder W, Bankl HC, et al. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology. 1996; 87:535-543. (Biology).
  3. Azorsa DO, Hildreth JEK. Schlossman SF, Boumsell L, Gilks W, et al, ed. Leucocyte Typing V. White Cell Differentiation Antigens. New York, NY: Oxford University Press Inc;
  4. Azorsa DO, Hyman JA, Hildreth JE. CD63/Pltgp40: a platelet activation antigen identical to the stage-specific, melanoma-associated antigen ME491. Blood. 1991; 78(2):280-284. (Biology). View Reference
  5. Brodsky FM. A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes.. Immunogenetics. 1984; 19(3):179-94. (Biology). View Reference
  6. Centers for Disease Control. Perspectives in disease prevention and health promotion update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR. 1988; 37:377-388. (Biology).
  7. Clinical and Laboratory Standards Institute. 2005. (Biology).
  8. Engleman EG, Warnke R, Fox RI, Dilley J, Benike CJ, Levy R. Studies of a human T lymphocyte antigen recognized by a monoclonal antibody.. Proc Natl Acad Sci USA. 1981; 78(3):1791-5. (Biology). View Reference
  9. Falcone FH, Haas H, Gibbs BF. The human basophil: a new appreciation of its role in immune responses. Blood. 2000; 96:4028-4038. (Biology).
  10. Gane P, Pecquet C, Crespeau H, Lambin P, Leynadier F, Rouger P. Flow cytometric monitoring of allergen induced basophil activation. Cytometry. 1995; 19:361-365. (Biology).
  11. Grouard G, Rissoan M-C, Filgueira L, Durand I, Banchereau J, Liu Y-J. The enigmatic plasmocytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 1997; 185:1101-1111. (Biology).
  12. Hart DN, McKenzie JL. Isolation and characterization of human tonsil dendritic cells. J Exp Med. 1988; 168:157-170. (Biology).
  13. Hildreth JE, Derr D, Azorsa DO. Characterization of a novel self-associating Mr 40,000 platelet glycoprotein. Blood. 1991; 77(1):121-132. (Biology). View Reference
  14. Lampson LA, Levy R. Two populations of Ia-like molecules on a human B cell line.. J Immunol. 1980; 125(1):293-9. (Biology). View Reference
  15. Levacher M, Tallet S, Dazza MC, Dournon E, Rouveix B, Pocidalo JJ. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.. Clin Exp Immunol. 1990; 81(2):177-82. (Biology). View Reference
  16. Miyajima A. CDw123 (Interleukin 3 receptor α chain) Workshop Panel report. In: Kishimoto T. Tadamitsu Kishimoto .. et al., ed. Leucocyte typing VI : white cell differentiation antigens : proceedings of the sixth international workshop and conference held in Kobe, Japan, 10-14 November 1996. New York: Garland Pub.; 1997:854-855.
  17. O'Doherty U, Peng M, Gezelter S, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature.. Immunology. 1994; 82(3):487-93. (Biology). View Reference
  18. Olweus J, BitMansour A, Warnke R, et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA. 1997; 94:12551-12556. (Biology).
  19. Sainte-Laudy J, Vallon C, Guerin JC. Diagnosis of latex allergy: comparison of histamine release and flow cytometric analysis of basophil activation. Inflamm Res. 1996; 45:S35-S36. (Biology).
  20. Smith WB, Guida L, Sun Q, et al. Neutrophils activated by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression. Blood. 1995; 86(10):3938-3944. (Biology). View Reference
  21. Stain C, Stockinger H, Scharf M, et al. Human blood basophils display a unique phenotype including activation linked membrane structures. Blood. 1987; 70:1872-1879. (Biology).
  22. Stites DP, Casavant CH, McHugh TM, et al. Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence.. Clin Immunol Immunopathol. 1986; 38(2):161-77. (Biology). View Reference
  23. Sun Q, Woodcock JM, Rapoport A, et al. Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist.. Blood. 1996; 87(1):83-92. (Biology). View Reference
  24. Terstappen LW, Hollander Z, Meiners H, Loken MR. Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukoc Biol. 1990; 48(2):138-148. (Biology). View Reference
  25. Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL. Activated lymphocytes during acute Epstein-Barr virus infection.. J Immunol. 1987; 139(11):3802-7. (Biology). View Reference
  26. Valent P, Besemer J, Muhm M, Majdic O, Lechner K, Bettelheim P. Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci USA. 1989; 86:5542-5546. (Biology).
  27. Valent P. Immunophenotypic characterization of human basophils and mast cells. Chem Immunol. 1995; 61:34-48. (Biology).
  28. Warnke R, Miller R, Grogan T, Pederson M, Dilley J, Levy R. Immunologic phenotype in 30 patients with diffuse large-cell lymphoma.. N Engl J Med. 1980; 303(6):293-300. (Biology). View Reference
  29. Warnke RA, Levy R. Detection of T and B cell antigens with hybridoma monoclonal antibodies: a biotinavidin-horseradish peroxidase method. J Histochem Cytochem. 1980; 28:771-776. (Biology).
  30. Zipf RF, Fox R, Dilley J, Levy R. Definition of the high risk ALL patient by immunologic phenotyping withmonoclonal antibodies. Cancer Res. 1981; 41:4786. (Biology).
  31. de Haas M, Azorsa DO. Kishimoto T, Kikutani H, von dem Borne AEGK, ed. Leucocyte Typing VI: White Cell Differentiation Antigens . New York, NY: Garland Publishing Inc; 1997:1160-1161.
View All (31) View Less
341068 Rev. 1

Please refer to Support Documents for Quality Certificates

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures. 

 

Although not required, these products are manufactured in accordance with Good Manufacturing Practices.